{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:04:26Z","timestamp":1772733866670,"version":"3.50.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R42DA43311"],"award-info":[{"award-number":["R42DA43311"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00213-019-5176-9","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T17:44:33Z","timestamp":1549475073000},"page":"2899-2907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists"],"prefix":"10.1007","volume":"236","author":[{"given":"Fang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"5176_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T (2001) Toll-like receptors : critical proteins linking innate and acquired immunity. Nat Immunol 2:675\u2013680. https:\/\/doi.org\/10.1038\/90609","journal-title":"Nat Immunol"},{"key":"5176_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.mad.2008.01.009","volume":"129","author":"JT Bates","year":"2008","unstructured":"Bates JT, Honko AN, Graff AH, Kock ND, Mizel SB (2008) Mucosal adjuvant activity of flagellin in aged mice. Mech Ageing Dev 129:271\u2013281. https:\/\/doi.org\/10.1016\/j.mad.2008.01.009","journal-title":"Mech Ageing Dev"},{"key":"5176_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature04596","volume":"440","author":"JM Blander","year":"2006","unstructured":"Blander JM, Medzhitov R (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440:808\u2013812. https:\/\/doi.org\/10.1038\/nature04596","journal-title":"Nature"},{"key":"5176_CR4","doi-asserted-by":"publisher","first-page":"E874","DOI":"10.1073\/pnas.1521359113","volume":"113","author":"CM Brackett","year":"2016","unstructured":"Brackett CM, Kojouharov B, Veith J, Greene KF, Burdelya LG, Gollnick SO, Abrams SI, Gudkov AV (2016) Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8 + T-cell axis. Proc Natl Acad Sci 113:E874\u2013E883. https:\/\/doi.org\/10.1073\/pnas.1521359113","journal-title":"Proc Natl Acad Sci"},{"key":"5176_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1021\/mp400631w","volume":"11","author":"PT Bremer","year":"2014","unstructured":"Bremer PT, Schlosburg JE, Lively JM, Janda KD (2014) Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy. Mol Pharm 11:1075\u20131080. https:\/\/doi.org\/10.1021\/mp400631w","journal-title":"Mol Pharm"},{"key":"5176_CR6","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1002\/anie.201511654","volume":"55","author":"PT Bremer","year":"2016","unstructured":"Bremer PT, Kimishima A, Schlosburg JE, Zhou B, Collins KC, Janda KD (2016) Combatting synthetic designer opioids : a conjugate vaccine ablates lethal doses of fentanyl class drugs. Angew Chem Int Ed Eng 55:3772\u20133775. https:\/\/doi.org\/10.1002\/anie.201511654","journal-title":"Angew Chem Int Ed Eng"},{"issue":"80","key":"5176_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1126\/science.1154986","volume":"320","author":"LG Burdelya","year":"2008","unstructured":"Burdelya LG, Krivokrysenko VI, Tallant TC et al (2008) An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320(80):226\u2013230. https:\/\/doi.org\/10.1126\/science.1154986","journal-title":"Science"},{"key":"5176_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijrobp.2011.05.055","volume":"83","author":"LG Burdelya","year":"2012","unstructured":"Burdelya LG, Gleiberman AS, Toshkov I, Aygun-Sunar S, Bapardekar M, Manderscheid-Kern P, Bellnier D, Krivokrysenko VI, Feinstein E, Gudkov AV (2012) Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys 83:228\u2013234. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.05.055","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5176_CR9","doi-asserted-by":"publisher","first-page":"E1857","DOI":"10.1073\/pnas.1222805110","volume":"110","author":"LG Burdelya","year":"2013","unstructured":"Burdelya LG, Brackett CM, Kojouharov B, Gitlin II, Leonova KI, Gleiberman AS, Aygun-Sunar S, Veith J, Johnson C, Haderski GJ, Stanhope-Baker P, Allamaneni S, Skitzki J, Zeng M, Martsen E, Medvedev A, Scheblyakov D, Artemicheva NM, Logunov DY, Gintsburg AL, Naroditsky BS, Makarov SS, Gudkov AV (2013) Central role of liver in anticancer and radioprotective activities of toll-like receptor 5 agonist. Proc Natl Acad Sci 110:E1857\u2013E1866. https:\/\/doi.org\/10.1073\/pnas.1222805110","journal-title":"Proc Natl Acad Sci"},{"key":"5176_CR10","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/0008-5472.CAN-10-1993","volume":"71","author":"Z Cai","year":"2011","unstructured":"Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D (2011) Activation of toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res 71:2466\u20132475. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1993","journal-title":"Cancer Res"},{"key":"5176_CR11","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1021\/ja400356g","volume":"135","author":"X Cai","year":"2013","unstructured":"Cai X, Tsuchikama K, Janda KD (2013a) Modulating cocaine vaccine potency through hapten fluorination. J Am Chem Soc 135:2971\u20132974. https:\/\/doi.org\/10.1021\/ja400356g","journal-title":"J Am Chem Soc"},{"key":"5176_CR12","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1021\/jm400228w","volume":"56","author":"X Cai","year":"2013","unstructured":"Cai X, Whitfield T, Hixon MS, Grant Y, Koob GF, Janda KD (2013b) Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design. J Med Chem 56:3701\u20133709. https:\/\/doi.org\/10.1021\/jm400228w","journal-title":"J Med Chem"},{"key":"5176_CR13","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1021\/jm901134w","volume":"52","author":"FI Carroll","year":"2009","unstructured":"Carroll FI, Abraham P, Gong PK, Pidaparthi RR, Blough BE, Che Y, Hampton A, Gunnell M, Lay JO Jr, Peterson EC, Owens SM (2009) The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse. J Med Chem 52:7301\u20137309. https:\/\/doi.org\/10.1021\/jm901134w","journal-title":"J Med Chem"},{"key":"5176_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jcph.450","volume":"55","author":"O Cohen-Barak","year":"2015","unstructured":"Cohen-Barak O, Wildeman J, Van De Wetering J et al (2015) Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects. J Clin Pharmacol 55:573\u2013583. https:\/\/doi.org\/10.1002\/jcph.450","journal-title":"J Clin Pharmacol"},{"key":"5176_CR15","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/acs.jmedchem.6b00084","volume":"59","author":"KC Collins","year":"2016","unstructured":"Collins KC, Schlosburg JE, Bremer PT, Janda KD (2016) Methamphetamine vaccines: improvement through Hapten design. J Med Chem 59:3878\u20133885. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00084","journal-title":"J Med Chem"},{"key":"5176_CR16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1086\/533467","volume":"46","author":"ACL Cooper","year":"2008","unstructured":"Cooper ACL, Angel JB, Seguin I et al (2008) CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term Seroprotection for up to 5 years linked references are available on JSTOR for this article : HIV \/ AIDS MAJOR ARTICLE CPG 7909 adjuvant plus hepatitis B virus V. Clin Infect Dis 46:1310\u20131314","journal-title":"Clin Infect Dis"},{"key":"5176_CR17","doi-asserted-by":"publisher","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","volume":"3","author":"J Cornuz","year":"2008","unstructured":"Cornuz J, Zwahlen S, Jungi WF, Osterwalder J, Klingler K, van Melle G, Bangala Y, Guessous I, M\u00fcller P, Willers J, Maurer P, Bachmann MF, Cerny T (2008) A vaccine against nicotine for smoking cessation : a randomized controlled trial. PLoS One 3:e2547. https:\/\/doi.org\/10.1371\/journal.pone.0002547","journal-title":"PLoS One"},{"key":"5176_CR18","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.4049\/jimmunol.175.12.8051","volume":"175","author":"NK Crellin","year":"2005","unstructured":"Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK (2005) Human CD4+ T cells express TLR5 and its ligand Flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 175:8051\u20138059. https:\/\/doi.org\/10.4049\/jimmunol.175.12.8051","journal-title":"J Immunol"},{"key":"5176_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.gastro.2011.12.001.Dysregulation","volume":"21","author":"R Dantzer","year":"2007","unstructured":"Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153\u2013160. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.001.Dysregulation","journal-title":"Brain Behav Immun"},{"key":"5176_CR20","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","volume":"183","author":"AM Didierlaurent","year":"2009","unstructured":"Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H, Kielland A, Vosters O, Vanderheyde N, Schiavetti F, Larocque D, van Mechelen M, Garcon N (2009) AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 183:6186\u20136197. https:\/\/doi.org\/10.4049\/jimmunol.0901474","journal-title":"J Immunol"},{"key":"5176_CR21","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.4049\/jimmunol.1201206","volume":"189","author":"X Ding","year":"2012","unstructured":"Ding X, Bian G, Leigh ND, Qiu J, McCarthy PL, Liu H, Aygun-Sunar S, Burdelya LG, Gudkov AV, Cao X (2012) A TLR5 agonist enhances CD8+ T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease. J Immunol 189:4719\u20134727. https:\/\/doi.org\/10.4049\/jimmunol.1201206","journal-title":"J Immunol"},{"key":"5176_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","volume":"239","author":"MS Duthie","year":"2011","unstructured":"Duthie MS, Windish HP, Fox CB, Reed SG (2011) Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev 239:178\u2013196. https:\/\/doi.org\/10.1111\/j.1600-065X.2010.00978.x","journal-title":"Immunol Rev"},{"key":"5176_CR23","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.4049\/jimmunol.166.2.1248","volume":"166","author":"T Eaves-Pyles","year":"2001","unstructured":"Eaves-Pyles T, Murthy K, Liaudet L, Virag L, Ross G, Soriano FG, Szabo C, Salzman AL (2001) Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I\u03baB\u03b1 degradation, induction of nitric oxide synthase, induction of Proinflammatory mediators, and cardiovascular dysfunction. J Immunol 166:1248\u20131260. https:\/\/doi.org\/10.4049\/jimmunol.166.2.1248","journal-title":"J Immunol"},{"key":"5176_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.cgt.7701004","volume":"14","author":"L Elia","year":"2007","unstructured":"Elia L, Aurisicchio L, Facciabene A, Giannetti P, Ciliberto G, la Monica N, Palombo F (2007) CD4+CD25+regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge. Cancer Gene Ther 14:201\u2013210. https:\/\/doi.org\/10.1038\/sj.cgt.7701004","journal-title":"Cancer Gene Ther"},{"key":"5176_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1176\/appi.ajp.2012.12060793","volume":"170","author":"I Esterlis","year":"2013","unstructured":"Esterlis I, Hannestad JO, Perkins E, Bois F, D\u2019Souza DC, Tyndale RF, Seibyl JP, Hatsukami DM, Cosgrove KP, O\u2019Malley SS (2013) Effect of a nicotine vaccine on nicotine binding to b 2 *-nicotinic acetylcholine receptors in vivo in human tobacco smokers. Am J Psychiatry 170:399\u2013407","journal-title":"Am J Psychiatry"},{"key":"5176_CR26","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.4049\/jimmunol.1202283","volume":"189","author":"A Flores-langarica","year":"2012","unstructured":"Flores-langarica A, Marshall JL, Cook C et al (2012) Systemic Flagellin immunization stimulates mucosal CD103+ dendritic cells and drives Foxp3+ regulatory T cell and IgA responses in the mesenteric lymph node. J Immunol 189:5745\u20135754. https:\/\/doi.org\/10.4049\/jimmunol.1202283","journal-title":"J Immunol"},{"key":"5176_CR27","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1003238","volume":"187","author":"N Fukuzawa","year":"2011","unstructured":"Fukuzawa N, Petro M, Baldwin WM, Gudkov AV, Fairchild RL (2011) A TLR5 agonist inhibits acute renal ischemic failure. J Immunol 187:3831\u20133839. https:\/\/doi.org\/10.4049\/jimmunol.1003238","journal-title":"J Immunol"},{"key":"5176_CR28","doi-asserted-by":"publisher","first-page":"120ra16","DOI":"10.1126\/scitranslmed.3002868","volume":"4","author":"J Garaude","year":"2012","unstructured":"Garaude J, Kent A, Van Rooijen N, Blander JM (2012) Cancer vaccines: simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses. Sci Transl Med 4:120ra16. https:\/\/doi.org\/10.1126\/scitranslmed.3002868","journal-title":"Sci Transl Med"},{"key":"5176_CR29","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","volume":"24","author":"SL Giannini","year":"2006","unstructured":"Giannini SL, Hanon E, Moris P, van Mechelen M, Morel S, Dessy F, Fourneau MA, Colau B, Suzich J, Losonksy G, Martin MT, Dubin G, Wettendorff MA (2006) Enhanced humoral and memory B cellular immunity using HPV16 \/ 18 L1 VLP vaccine formulated with the MPL \/ aluminium salt combination ( AS04 ) compared to aluminium salt only. Vaccine 24:5937\u20135949. https:\/\/doi.org\/10.1016\/j.vaccine.2006.06.005","journal-title":"Vaccine"},{"key":"5176_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1517\/17425255.3.2.209","volume":"3","author":"EJ Gribble","year":"2007","unstructured":"Gribble EJ, Sivakumar PV, Ponce RA, Hughes SD (2007) Toxicity as a result of immunostimulation by biologics. Expert Opin Drug Metab Toxicol 3:209\u2013234","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5176_CR31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/ajad.12307","volume":"24","author":"CN Haile","year":"2015","unstructured":"Haile CN, Kosten TA, Shen XY, O'Malley PW, Winoske KJ, Kinsey BM, Wu Y, Huang Z, Lykissa ED, Naidu N, Cox JA, Arora R, Kosten TR, Orson FM (2015) Altered methamphetamine place conditioning in mice vaccinated with a Succinyl-methamphetamine-tetanus-toxoid vaccine. Am J Addict 24:748\u2013755. https:\/\/doi.org\/10.1111\/ajad.12307","journal-title":"Am J Addict"},{"key":"5176_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/geot.201190038","volume":"67","author":"M Haney","year":"2010","unstructured":"Haney M, Gunderson EW, Jiang H et al (2010) Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biol Psychiatry 67:59\u201365. https:\/\/doi.org\/10.1002\/geot.201190038","journal-title":"Biol Psychiatry"},{"key":"5176_CR33","doi-asserted-by":"publisher","first-page":"e0118787","DOI":"10.1371\/journal.pone.0118787","volume":"10","author":"AC Harris","year":"2015","unstructured":"Harris AC, Le Sage MG, Shelley D et al (2015) The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats. PLoS One 10:e0118787. https:\/\/doi.org\/10.1371\/journal.pone.0118787","journal-title":"PLoS One"},{"key":"5176_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/clpt.2010.317","volume":"89","author":"DK Hatsukami","year":"2011","unstructured":"Hatsukami DK, Jorenby DE, Gonzales D, Rigotti NA, Glover ED, Oncken CA, Tashkin DP, Reus VI, Akhavain RC, Fahim REF, Kessler PD, Niknian M, Kalnik MW, Rennard SI (2011) Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther 89:392\u2013399. https:\/\/doi.org\/10.1038\/clpt.2010.317","journal-title":"Clin Pharmacol Ther"},{"key":"5176_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature 410:1099\u20131103","journal-title":"Nature"},{"key":"5176_CR36","doi-asserted-by":"publisher","first-page":"140ra187","DOI":"10.1038\/mt.2012.86","volume":"4","author":"MJ Hicks","year":"2012","unstructured":"Hicks MJ, Rosenberg JB, De BP et al (2012) AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation. Sci Transl Med 4:140ra187. https:\/\/doi.org\/10.1038\/mt.2012.86","journal-title":"Sci Transl Med"},{"key":"5176_CR37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-3565(24)37155-1","volume":"283","author":"Y Hieda","year":"1997","unstructured":"Hieda Y, Keyler DE, Vandevoort JT et al (1997) Active immunization alters the plasma nicotine concentration in rats. J Pharmocol Exp Ther 283:1076\u20131081","journal-title":"J Pharmocol Exp Ther"},{"key":"5176_CR38","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1016\/j.vaccine.2016.08.010","volume":"34","author":"BC Holbrook","year":"2016","unstructured":"Holbrook BC, Agostino RBD, Parks GD, Alexander-miller MA (2016) Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model. Vaccine 34:4712\u20134717. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.010","journal-title":"Vaccine"},{"key":"5176_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1385\/IR:33:1:083","volume":"33","author":"AN Honko","year":"2005","unstructured":"Honko AN, Mizel SB (2005) Effects of Flagellin on innate and adaptive immunity. Immunol Res 33:83\u2013101 doi: 10.1385\/IR","journal-title":"Immunol Res"},{"key":"5176_CR40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","volume":"74","author":"AN Honko","year":"2006","unstructured":"Honko AN, Sriranganathan N, Lees CJ, Mizel SB (2006a) Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 74:1113\u20131120. https:\/\/doi.org\/10.1128\/IAI.74.2.1113-1120.2006","journal-title":"Infect Immun"},{"key":"5176_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113","volume":"74","author":"AN Honko","year":"2006","unstructured":"Honko AN, Sriranganathan N, Lees CJ, Mizel SB (2006b) Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 74:1113\u20131120. https:\/\/doi.org\/10.1128\/IAI.74.2.1113","journal-title":"Infect Immun"},{"key":"5176_CR42","doi-asserted-by":"publisher","unstructured":"Hossain MS, Ramachandiran S, Gewirtz AT, Waller EK (2014) Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice. PLoS One 9(5):e96165. https:\/\/doi.org\/10.1371\/journal.pone.0096165","DOI":"10.1371\/journal.pone.0096165"},{"key":"5176_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1586\/14760584.6.5.773","volume":"6","author":"ST Ishizaka","year":"2007","unstructured":"Ishizaka ST, Hawkins LD (2007) E6020: a synthetic toll-like receptor 4 agonist as a vaccine adjuvant. Expert Rev Vaccines 6:773\u2013784","journal-title":"Expert Rev Vaccines"},{"key":"5176_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/imm.12549","volume":"147","author":"D Islam","year":"2016","unstructured":"Islam D, Lombardini E, Ruamsap N, Imerbsin R, Khantapura P, Teo I, Neesanant P, Gonwong S, Yongvanitchit K, Swierczewski BE, Mason CJ, Shaunak S (2016) Controlling the cytokine storm in severe bacterial diarrhoea with an oral toll-like receptor 4 antagonist. Immunology 147:178\u2013189. https:\/\/doi.org\/10.1111\/imm.12549","journal-title":"Immunology"},{"key":"5176_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/jat\/26.7.382","volume":"26","author":"AJ Jenkins","year":"2002","unstructured":"Jenkins AJ, Keenan RM, Henningfield JE, Cone EJ (2002) Correlation between pharmacological effects and plasma cocaine concentrations after smoked a d m i n i s t r a t i o n. J Anal Toxicol 26:382\u2013392","journal-title":"J Anal Toxicol"},{"key":"5176_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/gut.2010.223891","volume":"60","author":"RM Jones","year":"2011","unstructured":"Jones RM, Sloane VM, Wu H, Luo L, Kumar A, Kumar MV, Gewirtz AT, Neish AS (2011) Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity. Gut 60:648\u2013657. https:\/\/doi.org\/10.1136\/gut.2010.223891","journal-title":"Gut"},{"key":"5176_CR47","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nm1589","volume":"13","author":"H Kanzler","year":"2007","unstructured":"Kanzler H, Barrat FJ, Hessel EM, Coffman RL (2007) Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Nat Med 13:552\u2013559. https:\/\/doi.org\/10.1038\/nm1589","journal-title":"Nat Med"},{"key":"5176_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14622299050011361","volume":"1","author":"DE Keyler","year":"1999","unstructured":"Keyler DE, Hieda Y, Peter JS, Pentel PR (1999) Altered disposition of repeated nicotine doses in rats immunized against nicotine. Nicotine Tob Res 1:241\u2013249. https:\/\/doi.org\/10.1080\/14622299050011361","journal-title":"Nicotine Tob Res"},{"key":"5176_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-016-0160-y","volume":"4","author":"H Khong","year":"2016","unstructured":"Khong H, Overwijk WW (2016) Adjuvants for peptide-based cancer vaccines. J Immunother Cancer 4:1\u201311. https:\/\/doi.org\/10.1186\/s40425-016-0160-y","journal-title":"J Immunother Cancer"},{"key":"5176_CR50","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1172\/JCI33071","volume":"118","author":"S Kim","year":"2008","unstructured":"Kim S, Lalani S, Parekh VV, Vincent TL, Wu L, van Kaer L (2008) Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. J Clin Invest 118:2301\u20132315. https:\/\/doi.org\/10.1172\/JCI33071","journal-title":"J Clin Invest"},{"key":"5176_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.virol.2018.08.019","volume":"524","author":"K Kim","year":"2018","unstructured":"Kim K, Kwon Y, Lee Y et al (2018) Virus-like particles presenting fl agellin exhibit unique adjuvant e ff ects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic in fl uenza virus M2e protein vaccine. Virology 524:172\u2013181. https:\/\/doi.org\/10.1016\/j.virol.2018.08.019","journal-title":"Virology"},{"key":"5176_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12250-014-3379-0","volume":"29","author":"D Kozlova","year":"2014","unstructured":"Kozlova D, Sokolova V, Zhong M, Zhang E, Yang J, Li W, Yang Y, Buer J, Westendorf AM, Epple M, Yan H (2014) Calcium phosphate nanoparticles show an effective activation of the innate immune response in vitro and in vivo after functionalization with flagellin. Virol Sin 29:33\u201339. https:\/\/doi.org\/10.1007\/s12250-014-3379-0","journal-title":"Virol Sin"},{"key":"5176_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0135388","volume":"10","author":"VI Krivokrysenko","year":"2015","unstructured":"Krivokrysenko VI, Toshkov IA, Gleiberman AS, Krasnov P, Shyshynova I, Bespalov I, Maitra RK, Narizhneva NV, Singh VK, Whitnall MH, Purmal AA, Shakhov AN, Gudkov AV, Feinstein E (2015) The toll-like receptor 5 agonist entolimod mitigates lethal acute radiation syndrome in non-human primates. PLoS One 10:1\u201331. https:\/\/doi.org\/10.1371\/journal.pone.0135388","journal-title":"PLoS One"},{"key":"5176_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/jpet.116.233510","volume":"358","author":"AMS Kvello","year":"2016","unstructured":"Kvello AMS, Andersen JM, \u00d8iestad EL et al (2016) Pharmacological effects of a monoclonal antibody against 6-Monoacetylmorphine upon heroin-induced Locomotor activity and pharmacokinetics in mice. J Pharmacol Exp Ther 358:181\u2013189. https:\/\/doi.org\/10.1124\/jpet.116.233510","journal-title":"J Pharmacol Exp Ther"},{"key":"5176_CR55","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1016\/j.vaccine.2018.06.005","volume":"36","author":"RG Labastida-conde","year":"2018","unstructured":"Labastida-conde RG, Ram\u00edrez-pliego O, Peleteiro-olmedo M et al (2018) Flagellin is a Th1 polarizing factor for human CD4 + T cells and induces protection in a murine neonatal vaccination model of rotavirus infection. Vaccine 36:4188\u20134197. https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.005","journal-title":"Vaccine"},{"key":"5176_CR56","doi-asserted-by":"publisher","unstructured":"Leigh ND, Bian G, Ding X et al (2014) A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity. PLoS One 9(1):e85587. https:\/\/doi.org\/10.1371\/journal.pone.0085587","DOI":"10.1371\/journal.pone.0085587"},{"key":"5176_CR57","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1021\/nl061786n.Core-Shell","volume":"23","author":"JW Lockner","year":"2013","unstructured":"Lockner JW, Ho SO, McCague KC et al (2013) Enhancing nicotine vaccine immunogenicity with liposomes. Bioorg Med Chem Lett 23:975\u2013978. https:\/\/doi.org\/10.1021\/nl061786n.Core-Shell","journal-title":"Bioorg Med Chem Lett"},{"key":"5176_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1021\/mp500520r","volume":"12","author":"JW Lockner","year":"2015","unstructured":"Lockner JW, Eubanks LM, Choi JL, Lively JM, Schlosburg JE, Collins KC, Globisch D, Rosenfeld-Gunn RJ, Wilson IA, Janda KD (2015) Flagellin as carrier and adjuvant in cocaine vaccine development. Mol Pharm 12:653\u2013662. https:\/\/doi.org\/10.1021\/mp500520r","journal-title":"Mol Pharm"},{"key":"5176_CR59","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.4049\/jimmunol.171.8.4320","volume":"171","author":"K Lor\u00e9","year":"2003","unstructured":"Lor\u00e9 K, Betts MR, Brenchley JM et al (2003) Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol 171:4320\u20134328. https:\/\/doi.org\/10.4049\/jimmunol.171.8.4320","journal-title":"J Immunol"},{"key":"5176_CR60","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3892\/etm.2015.2914","volume":"11","author":"Y Ma","year":"2016","unstructured":"Ma Y, Zhang L, Li Q (2016) Expression levels of cytokines and chemokines increase in human peripheral blood mononuclear cells stimulated by activation of the toll-like receptor 5 pathway. Exp Ther Med 11:588\u2013592. https:\/\/doi.org\/10.3892\/etm.2015.2914","journal-title":"Exp Ther Med"},{"key":"5176_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/21655979.2015.1126017","volume":"7","author":"ES Mardanova","year":"2016","unstructured":"Mardanova ES, Kotlyarov RY, Kuprianov VV, Stepanova LA, Tsybalova LM, Lomonossoff GP, Ravin NV (2016) High immunogenicity of plant-produced candidate in fl uenza vaccine based on the M2e peptide fused to flagellin. Bioengineered 7:28\u201332. https:\/\/doi.org\/10.1080\/21655979.2015.1126017","journal-title":"Bioengineered"},{"key":"5176_CR62","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","volume":"66","author":"BA Martell","year":"2009","unstructured":"Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR (2009) Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double- blind, placebo-controlled efficacy trial. Arch Gen Psychiatry 66:1116\u20131123. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2009.128","journal-title":"Arch Gen Psychiatry"},{"key":"5176_CR63","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.4049\/jimmunol.169.7.3914","volume":"169","author":"SJ McSorley","year":"2002","unstructured":"McSorley SJ, Ehst BD, Yu Y, Gewirtz AT (2002) Bacterial Flagellin is an effective adjuvant for CD4+ T cells in vivo. J Immunol 169:3914\u20133919. https:\/\/doi.org\/10.4049\/jimmunol.169.7.3914","journal-title":"J Immunol"},{"key":"5176_CR64","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.4049\/jimmunol.170.10.5165","volume":"170","author":"TK Means","year":"2003","unstructured":"Means TK, Hayashi F, Smith KD, Aderem A, Luster AD (2003) The toll-like receptor 5 stimulus bacterial Flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 170:5165\u20135175. https:\/\/doi.org\/10.4049\/jimmunol.170.10.5165","journal-title":"J Immunol"},{"key":"5176_CR65","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1021\/nl061786n.Core-Shell","volume":"73","author":"M Miller","year":"2013","unstructured":"Miller M, Moreno A, Aarde S et al (2013) A methamphetamine vaccine attenuates methamphetamine- induced disruptions in thermoregulation and activity in rats. Biol Psychiatry 73:721\u2013728. https:\/\/doi.org\/10.1021\/nl061786n.Core-Shell","journal-title":"Biol Psychiatry"},{"key":"5176_CR66","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","volume":"185","author":"SB Mizel","year":"2010","unstructured":"Mizel SB, Bates JT (2010) Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 185:5677\u20135682. https:\/\/doi.org\/10.4049\/jimmunol.1002156","journal-title":"J Immunol"},{"key":"5176_CR67","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22:240\u2013273. https:\/\/doi.org\/10.1128\/CMR.00046-08","journal-title":"Clin Microbiol Rev"},{"key":"5176_CR68","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1128\/CVI.00153-07","volume":"14","author":"GL Morefield","year":"2007","unstructured":"Morefield GL, Hawkins LD, Ishizaka ST, Kissner TL, Ulrich RG (2007) Synthetic toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome. Clin Vaccine Immunol 14:1499\u20131504. https:\/\/doi.org\/10.1128\/CVI.00153-07","journal-title":"Clin Vaccine Immunol"},{"key":"5176_CR69","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1021\/ja108807j","volume":"133","author":"AY Moreno","year":"2011","unstructured":"Moreno AY, Mayorov AV, Janda KD (2011) Impact of distinct chemical structures for the development of a methamphetamine vaccine. J Am Chem Soc 133:6587\u20136595. https:\/\/doi.org\/10.1021\/ja108807j","journal-title":"J Am Chem Soc"},{"key":"5176_CR70","doi-asserted-by":"publisher","first-page":"44042","DOI":"10.1038\/srep44042","volume":"7","author":"Y Murakami","year":"2017","unstructured":"Murakami Y, Fukui R, Motoi Y, Shibata T, Saitoh SI, Sato R, Miyake K (2017) The protective effect of the anti-toll-like receptor 9 antibody against acute cytokine storm caused by immunostimulatory DNA. Sci Rep 7:44042. https:\/\/doi.org\/10.1038\/srep44042","journal-title":"Sci Rep"},{"key":"5176_CR71","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1124\/jpet.115.228825","volume":"356","author":"V Murthy","year":"2016","unstructured":"Murthy V, Reyes S, Geng L, Gao Y, Brimijoin S (2016) Cocaine hydrolase gene transfer demonstrates cardiac safety and efficacy against cocaine-induced QT prolongation in mice. J Pharmacol Exp Ther 356:720\u2013725. https:\/\/doi.org\/10.1124\/jpet.115.228825","journal-title":"J Pharmacol Exp Ther"},{"key":"5176_CR72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/10550887.2014.969603","volume":"33","author":"AF Nasser","year":"2014","unstructured":"Nasser AF, Fudala PJ, Zheng B, Liu Y, Heidbreder C (2014) A randomized, double-blind, placebo-controlled trial of RBP-8000 in cocaine abusers: pharmacokinetic profile of RBP-8000 and cocaine and effects of RBP-8000 on cocaine-induced physiological effects. J Addict Dis 33:289\u2013302. https:\/\/doi.org\/10.1080\/10550887.2014.969603","journal-title":"J Addict Dis"},{"key":"5176_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.drugalcdep.2005.08.004","volume":"82","author":"RA Nelson","year":"2006","unstructured":"Nelson RA, Boyd SJ, Ziegelstein RC, Herning R, Cadet JL, Henningfield JE, Schuster CR, Contoreggi C, Gorelick DA (2006) Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans. Drug Alcohol Depend 82:19\u201324. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.08.004","journal-title":"Drug Alcohol Depend"},{"key":"5176_CR74","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1128\/AAC.49.10.3991","volume":"49","author":"MG Netea","year":"2005","unstructured":"Netea MG, Van Der Meer JWM, Sutmuller RP et al (2005) From the Th1 \/ Th2 paradigm towards a toll-like Receptr\/T-helper bias. Antimicrob Agents Chemother 49:3991\u20133996. https:\/\/doi.org\/10.1128\/AAC.49.10.3991","journal-title":"Antimicrob Agents Chemother"},{"key":"5176_CR75","doi-asserted-by":"publisher","unstructured":"Ohia-Nwoko O, Kosten TA, Haile CN (2016) Animal models and the development of vaccines to treat substance use disorders. Int Rev Neurobiol 126:263\u2013291. https:\/\/doi.org\/10.1016\/bs.irn.2016.02.009","DOI":"10.1016\/bs.irn.2016.02.009"},{"key":"5176_CR76","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1517\/14712598.2014.920319","volume":"14","author":"FM Orson","year":"2014","unstructured":"Orson FM, Wang R, Brimijoin S, Kinsey BM, Singh RAK, Ramakrishnan M, Wang HY, Kosten TR (2014) The future potential for cocaine vaccines. Expert Opin Biol Ther 14:1271\u20131283. https:\/\/doi.org\/10.1517\/14712598.2014.920319","journal-title":"Expert Opin Biol Ther"},{"key":"5176_CR77","doi-asserted-by":"publisher","first-page":"40791","DOI":"10.1038\/srep40791","volume":"7","author":"L Perrin-Cocon","year":"2017","unstructured":"Perrin-Cocon L, Aublin-Gex A, Sestito SE, Shirey KA, Patel MC, Andr\u00e9 P, Blanco JC, Vogel SN, Peri F, Lotteau V (2017) TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection. Sci Rep 7:40791. https:\/\/doi.org\/10.1038\/srep40791","journal-title":"Sci Rep"},{"key":"5176_CR78","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1080\/21645515.2016.1212785","volume":"12","author":"M Pravetoni","year":"2016","unstructured":"Pravetoni M (2016) Biologics to treat substance use disorders: current status and new directions. Hum Vaccin Immunother 12:3005\u20133019. https:\/\/doi.org\/10.1080\/21645515.2016.1212785","journal-title":"Hum Vaccin Immunother"},{"key":"5176_CR79","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1124\/jpet.111.189506","volume":"341","author":"M Pravetoni","year":"2012","unstructured":"Pravetoni M, Le Naour M, Harmon TM et al (2012a) An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia. J Pharmacol Exp Ther 341:225\u2013232. https:\/\/doi.org\/10.1124\/jpet.111.189506","journal-title":"J Pharmacol Exp Ther"},{"key":"5176_CR80","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1002\/bmb.20244.DNA","volume":"31","author":"M Pravetoni","year":"2012","unstructured":"Pravetoni M, Raleigh M, Le Naour M et al (2012b) Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine 31:4617\u20134624. https:\/\/doi.org\/10.1002\/bmb.20244.DNA","journal-title":"Vaccine"},{"key":"5176_CR81","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/1348-0421.12396","volume":"60","author":"F Qian","year":"2016","unstructured":"Qian F, Yin J, Li M, Guo A, Li T, Zhou L, Wu X, Xu H (2016) Intranasal immunization with a peptide conjugated to Salmonella fl agellin induces both systemic and mucosal peptide-speci fi c antibody responses in mice. Microbiol Immunol 60:497\u2013500. https:\/\/doi.org\/10.1111\/1348-0421.12396","journal-title":"Microbiol Immunol"},{"key":"5176_CR82","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.20051720","volume":"203","author":"T Querec","year":"2006","unstructured":"Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203:413\u2013424. https:\/\/doi.org\/10.1084\/jem.20051720","journal-title":"J Exp Med"},{"key":"5176_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31\u201341. https:\/\/doi.org\/10.1001\/2013.jamapsychiatry.4","journal-title":"JAMA Psychiatry"},{"key":"5176_CR84","doi-asserted-by":"publisher","unstructured":"Raleigh M, Baruffaldi F, Peterson S et al (2019) A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats. J Pharmacol Exp Ther 368(2):282\u2013291. https:\/\/doi.org\/10.1124\/jpet.118.253674","DOI":"10.1124\/jpet.118.253674"},{"key":"5176_CR85","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/cbdd.12326","volume":"84","author":"M Ramakrishnan","year":"2014","unstructured":"Ramakrishnan M, Kinsey BM, Singh RA, Kosten TR, Orson FM (2014) Hapten optimization for cocaine vaccine with improved cocaine recognition. Chem Biol Drug Des 84:354\u2013363. https:\/\/doi.org\/10.1111\/cbdd.12326","journal-title":"Chem Biol Drug Des"},{"key":"5176_CR86","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1749-6632.2009.04939.x","volume":"1174","author":"AJ Rech","year":"2009","unstructured":"Rech AJ, Vonderheide RH (2009) Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Ann N Y Acad Sci 1174:99\u2013106. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04939.x","journal-title":"Ann N Y Acad Sci"},{"key":"5176_CR87","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/j.gastro.2008.04.022","volume":"135","author":"SH Rhee","year":"2008","unstructured":"Rhee SH, Im E, Pothoulakis C (2008) Toll-like receptor 5 engagement modulates tumor development and growth in a mouse Xenograft model of human Colon Cancer. Gastroenterology 135:518\u2013528. https:\/\/doi.org\/10.1053\/j.gastro.2008.04.022","journal-title":"Gastroenterology"},{"key":"5176_CR88","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.4049\/jimmunol.0901215","volume":"184","author":"S Rolla","year":"2010","unstructured":"Rolla S, Ria F, Occhipinti S, di Sante G, Iezzi M, Spadaro M, Nicolo C, Ambrosino E, Merighi IF, Musiani P, Forni G, Cavallo F (2010) Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. J Immunol 184:6124\u20136132. https:\/\/doi.org\/10.4049\/jimmunol.0901215","journal-title":"J Immunol"},{"key":"5176_CR89","doi-asserted-by":"publisher","first-page":"R160","DOI":"10.1186\/cc9235","volume":"14","author":"J Rolli","year":"2010","unstructured":"Rolli J, Loukili N, Levrand S, Rosenblatt-Velin N, Rignault-Clerc S, Waeber B, Feihl F, Pacher P, Liaudet L (2010) Bacterial flagellin elicits widespread innate immune defense mechanisms , apoptotic signaling , and a sepsis-like systemic inflammatory response in mice. Crit Care 14:R160","journal-title":"Crit Care"},{"key":"5176_CR90","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/hum.2011.178","volume":"23","author":"JB Rosenberg","year":"2012","unstructured":"Rosenberg JB, Hicks MJ, De BP et al (2012) AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior. Hum Gene Ther 23:451\u2013459. https:\/\/doi.org\/10.1089\/hum.2011.178","journal-title":"Hum Gene Ther"},{"key":"5176_CR91","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.4049\/jimmunol.179.9.6169","volume":"179","author":"R-M Salazar-Gonzalez","year":"2007","unstructured":"Salazar-Gonzalez R-M, Srinivasan A, Griffin A, Muralimohan G, Ertelt JM, Ravindran R, Vella AT, McSorley SJ (2007) Salmonella Flagellin induces bystander activation of splenic dendritic cells and hinders bacterial replication in vivo. J Immunol 179:6169\u20136175. https:\/\/doi.org\/10.4049\/jimmunol.179.9.6169","journal-title":"J Immunol"},{"key":"5176_CR92","doi-asserted-by":"publisher","first-page":"7184","DOI":"10.4049\/jimmunol.180.11.7184","volume":"180","author":"CJ Sanders","year":"2008","unstructured":"Sanders CJ, Moore DAI, Williams IR, Gewirtz AT (2008) Both Radioresistant and Hemopoietic cells promote innate and adaptive immune responses to Flagellin. J Immunol 180:7184\u20137192. https:\/\/doi.org\/10.4049\/jimmunol.180.11.7184","journal-title":"J Immunol"},{"key":"5176_CR93","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pbb.2009.05.008","volume":"93","author":"CW Schindler","year":"2009","unstructured":"Schindler CW, Panlilio LV, Thorndike EB (2009) Effect of rate of delivery of intravenous cocaine on self-administration in rats. Pharmacol Biochem Behav 93:375\u2013381. https:\/\/doi.org\/10.1016\/j.pbb.2009.05.008","journal-title":"Pharmacol Biochem Behav"},{"key":"5176_CR94","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.176.11.6624","volume":"176","author":"L Sfondrini","year":"2006","unstructured":"Sfondrini L, Rossini A, Besusso D, Merlo A, Tagliabue E, Menard S, Balsari A (2006) Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J Immunol 176:6624\u20136630. https:\/\/doi.org\/10.4049\/jimmunol.176.11.6624","journal-title":"J Immunol"},{"key":"5176_CR95","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4168\/aair.2016.8.3.206","volume":"8","author":"J Shim","year":"2016","unstructured":"Shim J, Rhee J, Jeong J, Koh Y (2016) Flagellin modulates the function of invariant NKT cells from patients with asthma via dendritic cells. Allergy, Asthma Immunol Res 8:206\u2013215","journal-title":"Allergy, Asthma Immunol Res"},{"key":"5176_CR96","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1124\/jpet.116.232504","volume":"357","author":"JR Smethells","year":"2016","unstructured":"Smethells JR, Swalve N, Brimijoin S, Gao Y, Parks RJ, Greer A, Carroll ME (2016) Long-term blockade of cocaine self-administration and Locomotor activation in rats by an adenoviral vector-delivered cocaine hydrolase. J Pharmacol Exp Ther 357:375\u2013381. https:\/\/doi.org\/10.1124\/jpet.116.232504","journal-title":"J Pharmacol Exp Ther"},{"key":"5176_CR97","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.4049\/jimmunol.165.6.3136","volume":"165","author":"KM Smith","year":"2000","unstructured":"Smith KM, Pottage L, Thomas ER, Leishman AJ, Doig TN, Xu D, Liew FY, Garside P (2000) Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol 165:3136\u20133144. https:\/\/doi.org\/10.4049\/jimmunol.165.6.3136","journal-title":"J Immunol"},{"key":"5176_CR98","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/653112","volume":"51","author":"OS S\u00f8gaard","year":"2010","unstructured":"S\u00f8gaard OS, Lohse N, Harboe ZB, Offersen R, Bukh AR, Davis HL, Sch\u00f8nheyder HC, \u00d8stergaard L (2010) Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV-Infected Adults with a Toll-Like Receptor 9 Agonist Adjuvant : A Randomized , Controlled Trial. Clin Infect Dis 51:42\u201350. https:\/\/doi.org\/10.1086\/653112","journal-title":"Clin Infect Dis"},{"key":"5176_CR99","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.4161\/19420862.2014.976431","volume":"6","author":"MW Stevens","year":"2014","unstructured":"Stevens MW, Henry RL, Owens SM, Schutz R, Gentry WB (2014) First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers. MAbs 6:1649\u20131656. https:\/\/doi.org\/10.4161\/19420862.2014.976431","journal-title":"MAbs"},{"key":"5176_CR100","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/anie.201602763.Digital","volume":"35","author":"MW Stevens","year":"2016","unstructured":"Stevens MW, Gunnell MG, Tawney R, Owens SM (2016) Optimization of a methamphetamine conjugate vaccine for antibody production in mice. Int Immunopharmacol 35:137\u2013141. https:\/\/doi.org\/10.1002\/anie.201602763.Digital","journal-title":"Int Immunopharmacol"},{"key":"5176_CR101","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/ilar.46.3.280","volume":"46","author":"HF Stills","year":"2005","unstructured":"Stills HF (2005) Adjuvants and antibody production: dispelling the myths associated with Freund\u2019s complete and other adjuvants. ILAR J 46:280\u2013293. https:\/\/doi.org\/10.1093\/ilar.46.3.280","journal-title":"ILAR J"},{"key":"5176_CR102","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfq134","volume":"117","author":"JM Tarrant","year":"2010","unstructured":"Tarrant JM (2010) Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use. Toxicol Sci 117:4\u201316. https:\/\/doi.org\/10.1093\/toxsci\/kfq134","journal-title":"Toxicol Sci"},{"key":"5176_CR103","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1016\/j.vaccine.2011.05.001","volume":"29","author":"DN Taylor","year":"2011","unstructured":"Taylor DN, Treanor JJ, Strout C, Johnson C, Fitzgerald T, Kavita U, Ozer K, Tussey L, Shaw A (2011) Induction of a potent immune response in the elderly using the TLR-5 agonist , flagellin , with a recombinant hemagglutinin influenza \u2013 flagellin fusion vaccine (VAX125, STF2.HA1 SI). Vaccine 29:4897\u20134902. https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.001","journal-title":"Vaccine"},{"key":"5176_CR104","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni.1622","volume":"9","author":"S Uematsu","year":"2008","unstructured":"Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M, Sato S, Tsujimura T, Yamamoto M, Yokota Y, Kiyono H, Miyasaka M, Ishii KJ, Akira S (2008) Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing toll-like receptor 5. Nat Immunol 9:769\u2013776. https:\/\/doi.org\/10.1038\/ni.1622","journal-title":"Nat Immunol"},{"key":"5176_CR105","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.4049\/jimmunol.180.12.8280","volume":"180","author":"M Vijay-Kumar","year":"2008","unstructured":"Vijay-Kumar M, Aitken JD, Sanders CJ, Frias A, Sloane VM, Xu J, Neish AS, Rojas M, Gewirtz AT (2008) Flagellin treatment protects against chemicals, Bacteria, viruses, and radiation. J Immunol 180:8280\u20138285. https:\/\/doi.org\/10.4049\/jimmunol.180.12.8280","journal-title":"J Immunol"},{"key":"5176_CR106","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.immuni.2016.05.005","volume":"44","author":"OH Voss","year":"2016","unstructured":"Voss OH, Murakami Y, Pena MY, Lee HN, Tian L, Margulies DH, Street JM, Yuen PST, Qi CF, Krzewski K, Coligan JE (2016) Lipopolysaccharide-induced CD300b receptor binding to toll-like receptor 4 alters signaling to drive cytokine responses that enhance septic shock. Immunity 44:1365\u20131378. https:\/\/doi.org\/10.1016\/j.immuni.2016.05.005","journal-title":"Immunity"},{"key":"5176_CR107","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/hep.29140","volume":"65","author":"L Wang","year":"2017","unstructured":"Wang L, Zhang W, Ge CH, Yin RH, Xiao Y, Zhan YQ, Yu M, Li CY, Ge ZQ, Yang XM (2017) Toll-like receptor 5 signaling restrains T-cell\/natural killer T-cell activation and protects against concanavalin A\u2013induced hepatic injury. Hepatology 65:2059\u20132073. https:\/\/doi.org\/10.1002\/hep.29140","journal-title":"Hepatology"},{"key":"5176_CR108","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejphar.2004.01.003","volume":"486","author":"WL Woolverton","year":"2004","unstructured":"Woolverton WL, Wang Z (2004) Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine. Eur J Pharmacol 486:251\u2013257. https:\/\/doi.org\/10.1016\/j.ejphar.2004.01.003","journal-title":"Eur J Pharmacol"},{"key":"5176_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18632\/oncotarget.6500","volume":"7","author":"H Yang","year":"2015","unstructured":"Yang H, Brackett CM, Morales-tirado VM et al (2015) The etoll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism. Oncotarget 7:1\u201315. https:\/\/doi.org\/10.18632\/oncotarget.6500","journal-title":"Oncotarget"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-5176-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-019-5176-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-5176-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:36:12Z","timestamp":1744176972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-019-5176-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":109,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["5176"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-5176-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"22 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of both authors, the corresponding author states that there is no conflict of interest. Our vaccine studies are in collaboration with Cleveland Biologic Labs (CBLI) who are providing Entolimod free of charge.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}